Osteoporosis treatment withdrawn from market


Patients currently taking strontium ranelate (Protos) will be forced to switch to another osteoporosis treatment as the drug has been permanently discontinued. The move follows warnings about the drug’s safety profile although pharmaceutical company Servier has said their decision ‘is not related to a quality or safety issue’. The drug was removed from the PBS ...


Already a member? Login to keep reading


OR
© 2017 the limbic